CompletedNot Applicable

Physical Activity Levels and Statin Therapy

Netherlands196 participantsStarted 2021-01-01

Plain-language summary

Rationale: Combining statin treatment and physical activity is very effective for the prevention of cardiovascular diseases. Statins are well-tolerated by most patients, but may cause statin-associated muscle symptoms (SAMS). Objective: To identify predictors for SAMS in statin users and to objectively assess physical activity levels and sedentary time between symptomatic and asymptomatic statin users.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Mentally able to give informed consent * Statin treatment for at least 3 months Exclusion Criteria: * Known hereditary muscle defect * Known mitochondrial disease * Other diseases known to cause muscle symptoms (e.g. m. Parkinson or rheumatic diseases)

What they're measuring

Physical activity

Timeframe: during 1 week

Sedentary time

Timeframe: during 1 week

Trial details

NCT IDNCT05625945

SponsorRadboud University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11-16

View on ClinicalTrials.gov More Cardiovascular Diseases trials